✦ LIBER ✦

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2+ Breast Cancer

✍ Scribed by Denise A. Yardley; Eric Raefsky; Raul Castillo; Anup Lahiry; Richard LoCicero; Dana Thompson; Mythili Shastry; Howard A. Burris III; John D. Hainsworth

Book ID: 113538926
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 370 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.04.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and Carboplatin as Neoadjuvan

Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group

✍ Helen Gogas; Dimitrios Pectasides; Ioannis Kostopoulos; Evangelos Lianos; Dimost 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 847 KB

Phase II study of preoperative systemic

Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer

✍ Masataka Sawaki; Hiroji Iwata; Yasuyuki Sato; Masaki Wada; Tatsuya Toyama; Eiich 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 635 KB

Results of a phase II study of liposomal

Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

✍ J Baselga; M.A Climent; A Lluch; J Hornedo; P Gascon; A.T Sanchez; V Guillem; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Phase II study of weekly docetaxel (Taxo

Phase II study of weekly docetaxel (Taxotere; txt) and trastuzumab (Herceptin; H) for patients with HER-2 overexpressing (HER2+) metastatic breast cancer (MBC)

✍ F.J. Esteva; V. Valero; D. Booser; L.T. Guerra; J.L. Murray; L. Pusztai; M. Cris 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 198 KB

A Randomized Phase II Study of Paclitaxe

A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast Cancer

✍ Adam Brufsky; Karen Hoelzer; Thaddeus Beck; Robert Whorf; Mark Keaton; Padma Nad 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 441 KB

Phase II study of neoadjuvant treatment

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

✍ Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 214 KB